These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. Silins E; Copeland J; Dillon P Aust N Z J Psychiatry; 2007 Aug; 41(8):649-55. PubMed ID: 17620161 [TBL] [Abstract][Full Text] [Related]
3. Death by "ecstasy": the serotonin syndrome? Mueller PD; Korey WS Ann Emerg Med; 1998 Sep; 32(3 Pt 1):377-80. PubMed ID: 9737504 [TBL] [Abstract][Full Text] [Related]
4. Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Demirkiran M; Jankovic J; Dean JM Clin Neuropharmacol; 1996 Apr; 19(2):157-64. PubMed ID: 8777769 [TBL] [Abstract][Full Text] [Related]
5. Oral health sensations associated with illicit drug abuse. McGrath C; Chan B Br Dent J; 2005 Feb; 198(3):159-62; dicussion 147; quiz 174. PubMed ID: 15706386 [TBL] [Abstract][Full Text] [Related]
6. Ecstasy (MDMA) and oral health. Brand HS; Dun SN; Nieuw Amerongen AV Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544 [TBL] [Abstract][Full Text] [Related]